Mr. Baxter is the former Senior Vice President, R&D Finance and Operations, of GlaxoSmithKline (GSK). In his 19 years of pharma experience, he has held line management roles in commercial, manufacturing, IT and the office of the CEO. His most recent position from 2002 to 2006 in R&D included responsibility for finance, pipeline resource planning and allocation, business development deal structuring and SROne (GSK’s in house $125m venture capital fund). He also chaired GSK’s R&D Operating Board. Prior to GSK, Jeff worked at Unilever and British American Tobacco. He was educated at Thames Valley University and is a Fellow of the Chartered Institute of Management Accountants (FCMA).

TCG Board Representation: 3-V Biosciences, Immune Design Corp.